Zobrazeno 1 - 10
of 84
pro vyhledávání: '"T J, Hamblin"'
Publikováno v:
Scandinavian Journal of Haematology. 36:221-228
A 56-yr-old Caucasian man presented with a generalised scaly rash and a peripheral blood lymphocytosis of 5.6 times 109/l. 5 yr later he developed cutaneous nodules, lymphadenopathy and hepatosplenomegaly. Cells with convoluted nuclei and prominent n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::262e418b3624c9f5e29883b86335da3d
https://doi.org/10.1111/j.1600-0609.1986.tb00832.x
https://doi.org/10.1111/j.1600-0609.1986.tb00832.x
Autor:
A. D. Hamblin, T. J. Hamblin
Publikováno v:
British Medical Bulletin. 87:49-62
Patients with chronic lymphocytic leukaemia (CLL) have progressive immunodeficiency and infection is the commonest cause of death. This review seeks to identify the extent of the abnormality, its cause, clinical significance and any possible remedy.T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edd259020e1c858105edd23ffdd19184
https://doi.org/10.1093/bmb/ldn034
https://doi.org/10.1093/bmb/ldn034
Publikováno v:
The Journal of Immunology. 159:1885-1892
Idiotypic determinants can act as tumor-associated Ags for B cell lymphoma. Vaccination with idiotypic protein and adjuvant is known to induce specific protection against lymphoma challenge in mice, largely mediated by anti-idiotypic Ab. For facilita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37cec739482abd0f232b1c643c088269
https://doi.org/10.4049/jimmunol.159.4.1885
https://doi.org/10.4049/jimmunol.159.4.1885
Publikováno v:
Blood. 95:2455-2457
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3e1431d09100666b9580d7d35862703
https://doi.org/10.1182/blood.v95.7.2455
https://doi.org/10.1182/blood.v95.7.2455
Autor:
T. J. Hamblin
Publikováno v:
Current Topics in Microbiology and Immunology ISBN: 3540252797
The chronic lymphatic leukaemia (CLL) world was surprised to find that the disease split so neatly down the middle into those patients with unmutated immunoglobulin genes who were mainly men, had aggressive disease and were destined to die from their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6b83f6467e45ef146e224bbb4ade6f2
https://doi.org/10.1007/3-540-29933-5_10
https://doi.org/10.1007/3-540-29933-5_10
Autor:
T J, Hamblin
Publikováno v:
Current topics in microbiology and immunology. 294
The chronic lymphatic leukaemia (CLL) world was surprised to find that the disease split so neatly down the middle into those patients with unmutated immunoglobulin genes who were mainly men, had aggressive disease and were destined to die from their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f2c992dfb677aa705778ad74521a61f1
https://pubmed.ncbi.nlm.nih.gov/16323432
https://pubmed.ncbi.nlm.nih.gov/16323432
The classification of B cell tumors has relevance for refining and improving clinical strategies. However, consensus has been difficult to establish, and although a scheme is now available, objective criteria are desirable. Genetic technology will un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c7877aebb0e7d59bb0f05ea76240c4de
http://hdl.handle.net/11365/26796
http://hdl.handle.net/11365/26796
Publikováno v:
Seminars in hematology. 36(1 Suppl 3)
Multiple myeloma is almost invariably fatal despite a wide variety of chemotherapeutic and supportive treatment options. There are several unresolved problems with existing approaches, including the specific indications for treatment; the optimal com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6a826f03dd40b81be896711878d3fc71
https://pubmed.ncbi.nlm.nih.gov/9989482
https://pubmed.ncbi.nlm.nih.gov/9989482
Publikováno v:
Seminars in hematology. 36(1 Suppl 3)
Monoclonal antibody therapy has emerged as a viable treatment option for patients with lymphoma and some leukemias. It is now beginning to be investigated for treatment of multiple myeloma. There are relatively few surface antigens on the plasma cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c1870a694591fd7e985f565509ef0469
https://pubmed.ncbi.nlm.nih.gov/9989487
https://pubmed.ncbi.nlm.nih.gov/9989487
Autor:
J M, Bennett, T J, Hamblin
Publikováno v:
Leukemia research. 22(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b4e4c08619fff50521b2e86bcc9e9307
https://pubmed.ncbi.nlm.nih.gov/9766744
https://pubmed.ncbi.nlm.nih.gov/9766744